Preferential Acquisition and Activation of Plasminogen Glycoform II by PAM Positive Group A Streptococcal Isolates

David M P De Oliveira1, Ruby H P Law2, Diane Ly1

  • 1†Illawarra Health and Medical Research Institute, School of Biological Sciences, University of Wollongong, Wollongong 2522, Australia.

Biochemistry
|June 2, 2015
PubMed

Insights

Group A Streptococcus selectively binds and activates a specific form of plasminogen (Plg), glycoform II Plg (GII-Plg), over glycoform I Plg (GI-Plg). This interaction is crucial for GAS virulence and may involve secondary binding sites.

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • Plasminogen (Plg) exists as two main glycoforms: GI-Plg (glycosylated at Asn289 and Thr346) and GII-Plg (glycosylated only at Thr346).
  • Group A Streptococcus (GAS) utilizes host plasminogen for virulence, with the M protein (PAM) being a key Plg-binding factor.

Purpose of the Study:

  • To investigate the differential binding affinities and activation kinetics of GAS PAM for GI-Plg and GII-Plg.
  • To elucidate the role of glycosylation and lysine-binding sites in the PAM-Plg interaction.

Main Methods:

  • Surface plasmon resonance (SPR) to measure binding affinities (KD) of PAM to GI-Plg and GII-Plg in different Plg conformations.
  • Inhibition assays using lysine analogue ε-aminocaproic acid (εACA) to probe the involvement of lysine-binding sites.
  • Assessment of Plg activation by a specific GAS SK variant (type 2b SK).

Main Results:

  • PAM exhibited similar affinity for both GI-Plg and GII-Plg in the 'closed' Plg conformation.
  • PAM showed an 11-fold higher affinity for GII-Plg compared to GI-Plg in the 'open' Plg conformation.
  • PAM-GII-Plg interaction was less sensitive to εACA inhibition than PAM-GI-Plg, suggesting involvement of sites beyond KR2.
  • Type 2b SK preferentially activated GII-Plg in the presence of PAM.

Conclusions:

  • GAS selectively recruits and activates GII-Plg over GI-Plg.
  • Glycosylation at Asn289 in GI-Plg may influence PAM binding, potentially through secondary sites.
  • The differential interaction with Plg glycoforms likely contributes to GAS pathogenesis.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.9K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
104
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
89